Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-Dose Antioxidant Treatment in Cystic Fibrosis
2013-005481-19Phase 2Completed
- Sponsor
- Aarhus University Hospital
- Start
- May 2014
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of acetylcysteine and glutathione in cystic fibrosis (CF), sponsored by Aarhus University Hospital. Primary endpoint: Neutrophil lung inflammation by PET/CT. Started May 2014; status: completed.
02
Drugs
acetylcysteineglutathione
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on 2013-005481-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-005481-19.